Report #2899535

Received Jun 23, 2026

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 60 yrs
State: IL
Recovered: Recovered
Vaccinated: Jun 3, 2026
Onset: Jun 4, 2026
Days to onset: 1
Hospital days: —

Vaccines (8)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	N/A	Z013655	IM / LA
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	N/A	KH9KK	IM / LA
TDAP	TDAP (ADACEL)	SANOFI PASTEUR	N/A	U8906AA	IM / LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	4A4BM	IM / LA
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	1	z013655	LA
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	kh9kk	LA
TDAP	TDAP (ADACEL)	SANOFI PASTEUR	1	u8906aa	IM / LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	4a4bm	LA

Symptoms (7)

Injection site erythemaInjection site painInjection site swellingCellulitisPainPyrexiaRash erythematous

Symptom narrative

Patient stated feeling redness and pain towards the end of the day after receiving vaccination, developing red bumps and as determined by Md to be cellulitis after repoprted symptoms of pain feverish red bumps.

Current illness

NONE KNOWN

Medical history

HEART (STENTS) DIABETIC(NO INSULIN/MAINTAINS W DIET), IBS AND ESOPHAGEAL HERNIA,,ILIAC ANEURYSM UNDER MEDICAL MONITORING BY PCP

Other medications

MAGNESIUM AND POTASSIUM SUPPLEMENTS, VITAMIN C , BIOTIN, PROBIOTIC

Allergies

NAPROXEN SULFATE

Lab data

no diagnostic labs needed provided empiric antibiotic with cephalexin